PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer.
Saved in:
| Title: | PTEN Loss and BRCA1 Promoter Hypermethylation Negatively Predict for Immunogenicity in BRCA-Deficient Ovarian Cancer. |
|---|---|
| Authors: | Kraya, Adam A.1 (AUTHOR), Maxwell, Kara N.2 (AUTHOR), Eiva, Monika A.3 (AUTHOR), Wubbenhorst, Bradley1 (AUTHOR), Pluta, John1 (AUTHOR), Feldman, Michael3 (AUTHOR), Nayak, Anupma3 (AUTHOR), Powell Jr, Daniel J.3 (AUTHOR), Domchek, Susan M.2,4 (AUTHOR), Vonderheide, Robert H.2,4 (AUTHOR), Nathanson, Katherine L.2,4 (AUTHOR) knathans@upenn.edu |
| Source: | JCO Precision Oncology. 2/24/2022, Vol. 6, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 24734284 |
|---|---|
| DOI: | 10.1200/PO.21.00159 |
